Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial
Telehealth has accelerated this redistribution of prescribing authority
This article is exclusive to STAT+ subscribers Unlock this article and get additional analysis of the technologies disrupting health care by subscribing to STAT+
Weight loss at the Retatrutide starting dose level is modest, but builds significantly as the dose increases
1 2 "First generic weight-loss injection approved in Canada", CTV News website , archived from the original on 30 June 2026 1 2 3 "Health Canada approves generic Ozempic from Apotex, country's largest drug maker", The Globe and Mail website , archived from the original on 1 May 2026 "Health Canada approves 2nd generic version of Ozempic and it's Canadian", The Canadian Press website , archived from the original on 15 May 2026 "1st generic semaglutide injection for weight loss approved: Health Canada", CBC News website , archived from the original on 30 June 2026 "Details for: SEVMIA", Drug and Health Product Portal , Health Canada, 29 June 2026, archived from the original on 29 June 2026 "Cheaper, generic versions of Ozempic could come to Canada as early as next year"
Positive reviews often highlight this difference, while complaints about fat burners tend to focus on tolerance build-up and rebound crashes
